Risk factors for long-term cardiovascular post-acute sequelae of COVID-19 infection: A nested case-control study in
Qiuyan Yu1,2, Min Fan1, Celia Jiaxi Lin3
1Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Insights
COVID-19 hospitalization and peripheral vascular disease increase cardiac PASC risk. COVID-19 vaccination and frequent healthcare visits are protective factors against cardiac PASC, especially for high-risk individuals.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Post-acute sequelae of SARS-CoV-2 (PASC) can affect multiple organ systems, including the cardiovascular system.
- Cardiac-related PASC presents a significant health burden following COVID-19 infection.
- Understanding risk factors for cardiac PASC is crucial for targeted prevention and management strategies.
Purpose of the Study:
- To investigate the risk factors associated with cardiac-related PASC.
- To identify specific pre-existing conditions and demographic factors that predispose individuals to cardiac PASC.
- To evaluate the potential protective effects of COVID-19 vaccination and healthcare utilization on cardiac PASC development.
Main Methods:
- A nested case-control study design was employed using electronic health records from the Hong Kong Hospital Authority.
- Cases were defined as patients with at least one cardiac-related PASC diagnosis, and controls were matched individuals without cardiac PASC.
- Multivariable conditional logistic regression analysis was used to identify associations between risk factors and cardiac-related PASC, with incidence density sampling for control selection (1:10 ratio).
Main Results:
- COVID-19-associated hospitalization (aOR: 1.41) and peripheral vascular disease (aOR: 2.98) were significantly associated with an increased risk of cardiac-related PASC.
- Higher doses of COVID-19 vaccination demonstrated a protective effect (2 doses: aOR 0.68; ≥3 doses: aOR 0.56).
- Increased healthcare utilization visits (aOR: 0.95) were also linked to a reduced likelihood of developing cardiac-related PASC.
Conclusions:
- Peripheral vascular disease and hospitalization due to COVID-19 are identified as key risk factors for cardiac-related PASC in this Chinese population cohort.
- COVID-19 vaccination confers protection against cardiac PASC, highlighting its importance in mitigating post-infection cardiovascular complications.
- Prioritizing vaccination for high-risk individuals is recommended to reduce the incidence of cardiac-related PASC.
Abstract:
People with COVID-19 can experience post-acute sequelae of SARS-CoV-2 (PASC). Studies on risk factors of PASC outcomes are ongoing, especially for endocrine system-related diseases that may impact the cardiovascular system. Cardiac-related PASC is one of the burdens after COVID-19 infection. This study aimed to examine the risk factors of cardiac-related PASC. In this nested case-control study, we obtained electronic health records (EHRs) database from the Hong Kong Hospital Authority. We defined cases as patients with at least one cardiac-related PASC and controls as patients without any cardiac-related PASC. We applied the incidence density sampling and matched controls to cases on age and sex at a 1:10 ratio. Multivariable conditional logistic regression was used to determine the associations between risk factors and cardiac-related PASC. A total of 455 individuals with cardiac-related PASC and matched 3,423 controls were obtained in the underlying cohort. COVID-19-associated hospitalisation (aOR: 1.41, 95% CI: 1.03-1.93) and peripheral vascular disease (aOR: 2.98, 95% CI: 1.31-6.79) were associated with an increased likelihood of cardiac-related PASC. Higher doses of the COVID-19 vaccine (2 doses: 0.68 [0.52-0.89]; ≥3 doses: 0.56 [0.40-0.78]) and more frequent healthcare utilization visits (aOR: 0.95, 95% CI: 0.92-0.97) were associated with a lower likelihood of cardiac-related PASC. This is the first study to examine risk factors of cardiac-related PASC among the Chinese population. We identified peripheral vascular disease and COVID-19-associated hospitalisation as the risk factors for cardiac-related PASC. COVID-19 vaccination was protective against cardiac-related PASC, which should be prioritized for high-risk patients.
Related Concept Videos
Longitudinal Studies
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

